Although the response rate to ICIs in ovarian cancer is usually lower than in other cancer types, a proportion of ovarian cancers exhibiting MSI show an increased number of CD3 + and CD8 + tumor infiltrating lymphocytes [50, 51]. Here, CD8A is linked to ovarian carcinoma.